用户名:
密 码:
注册
|
忘记密码?
首 页
药品信息
药品检索
全部药品
适应症分类
热门药品
专利信息
专利检索
专利权人导航
专利权人分组导航
分类查询
IPC导航
热门检索
专利分析
概况
申请趋势分析
申请人分析
发明人分析
IPC分析
项目文档
项目
个人项目
文档
个人文档
企业文档
公共文档
标签
互动
特色功能
广州科技订制咨询
特色资讯
医药新闻
帮助中心
关于本软件
药品
文档
专利
新闻
所有专利
选择导航
专利权人导航
专利权人分组导航
分类导航
专利权人导航
XENOPORT INC [US](12)
Xenoport, Inc.(8)
SYNCHRONEURON LLC [US](7)
PHARNEXT [FR](6)
PHARNEXT(6)
LI YUNXIAO [US](5)
JANDELEIT BERND [US](5)
ZERANGUE NOA [US](5)
VIRSIK PETER A [US](5)
FISCHER WOLF-NICOLAS [US](5)
专利信息
Translation Company
查询条件
展开筛选条件
[药品] 包含 'Acamprosate'
清空条件
查询
分析
排序
公开日
公开号
申请日
申请号
中文标题
英文标题
降序
升序
翻到页码
标题
标题2
专利权人
发明人
附图
摘要
摘要2
优先权号
IPC
专利类型
首页
1
2
3
4
5
6
下页
尾页
共
114
条记录, 当前第1/12页。
公开号
公开日
申请号
申请日
1.
WO2014037412A1
2014/3/13
WO2013EP68302
2013/9/4
专利标题
:NOOTROPIC COMPOSITIONS FOR IMPROVING MEMORY PERFORMANCE
专利权人
:
PHARNEXT [FR]
;
The invention relates to compositions and methods for improving memory and related functions as alertness, attention, concentration, learning, and language processing. More particularly, the invention relates to compositions comprising at least two drugs selected from cinacalcet, baclofen, acamprosate, mexiletine, sulfisoxazole and torasemide useful to enhance memory and related functions in healthy subjects or subjects suffering from conditions or disorders having a negative impact on their mem...
2.
EP2705841A1
2014/3/12
EP20120306062
2012/9/5
专利标题
:Combinations of nootropic agents for treating cognitive dysfunctions
专利权人
:
PHARNEXT [FR]
;
The invention relates to compositions and methods for improving memory and related functions as alertness, attention, concentration, learning, and language processing. More particularly, the invention relates to compositions comprising at least two drugs selected from cinacalcet, baclofen, acamprosate, mexiletine, sulfisoxazole and torasemide useful to enhance memory and related functions in healthy subjects or subjects suffering from conditions or disorders having a negative impact on their mem...
3.
CN101492400B
2014/3/12
CN2008156550
2008/1/22
专利标题
:A kind of preparation method of high-purity acamprosate calcium
专利权人
:
Beijing Huaxi Lianhe Technology Development Co., Ltd.
;
4.
CN103596562A
2014/2/19
CN2012817651
2012/3/1
专利标题
:Neurological disorder therapy based on baclofen and acamprosate
专利权人
:
5.
WO2014018468A1
2014/1/30
WO2013US51550
2013/7/22
专利标题
:MODULATION SAPP, SAPP ALPHA AND BDNF LEVELS IN INDIVIDUALS DIAGNOSED WITH FXS AND ASD
专利权人
:
UNIV INDIANA RES & TECH CORP [US]
;
A method of treating and monitoring patient diagnosed with Autistic Spectrum disorder or Fragile X syndrome comprising measuring plasma biomarker levels of BDNF, sAPP, and sAPP alpha and adjusting the amount of a therapeutic compound according to the plasma levels of BDNF, sAPP and sAPPs. In one embodiment, the therapeutic compound is acamprosate.
6.
EP2560631B1
2014/1/15
EP20120708113
2012/3/1
专利标题
:Baclofen and acamprosate based therapy of neurogical disorders
专利权人
:
PHARNEXT
;
7.
US20130310456A1
2013/11/21
US13/891110
2013/5/9
专利标题
:Acamprosate formulations, methods of using the same, and combinations comprising the same
专利权人
:
Synchroneuron Inc.
;
Embodiments disclosed herein generally relate to acamprosate formulations methods of use of the formulations to methods of using the formulations in combination with at least one other medication and to combination products and compositions comprising the formulations and at least one other medication such as neuroleptic (antipsychotic) and/or antidepressant drugs.
8.
US20130310455A1
2013/11/21
US13/891102
2013/5/9
专利标题
:Acamprosate formulations, methods of using the same, and combinations comprising the same
专利权人
:
Synchroneuron Inc.
;
Embodiments disclosed herein generally relate to acamprosate formulations methods of use of the formulations to methods of using the formulations in combination with at least one other medication and to combination products and compositions comprising the formulations and at least one other medication such as neuroleptic (antipsychotic) and/or antidepressant drugs.
9.
US2013310456A1
2013/11/21
US201313891110
2013/5/9
专利标题
:ACAMPROSATE FORMULATIONS, METHODS OF USING THE SAME, AND COMBINATIONS COMPRISING THE SAME
专利权人
:
SYNCHRONEURON INC [US]
;
SYNCHRONEURON INC [US]
;
Embodiments disclosed herein generally relate to acamprosate formulations, methods of use of the formulations, to methods of using the formulations in combination with at least one other medication, and to combination products and compositions comprising the formulations and at least one other medication, such as neuroleptic (antipsychotic) and/or antidepressant drugs.
10.
US2013310455A1
2013/11/21
US201313891102
2013/5/9
专利标题
:ACAMPROSATE FORMULATIONS, METHODS OF USING THE SAME, AND COMBINATIONS COMPRISING THE SAME
专利权人
:
SYNCHRONEURON INC [US]
;
SYNCHRONEURON INC [US]
;
Embodiments disclosed herein generally relate to acamprosate formulations, methods of use of the formulations, to methods of using the formulations in combination with at least one other medication, and to combination products and compositions comprising the formulations and at least one other medication, such as neuroleptic (antipsychotic) and/or antidepressant drugs.
首页
1
2
3
4
5
6
下页
尾页
共
114
条记录, 当前第1/12页。
当前查询条件: [药品] 包含 'Acamprosate'
查询范围
在当前结果中查询
!
专利类型
发明
实用新型
外观设计
!
公开号
CN1234
!
申请号
CN1234
!
专利标题
扩展
PHARMA
!
专利权人
扩展
pfizer
发明人
!
申请日
yyyymmdd
!
公开日
yyyymmdd
优先权号
!
摘要
扩展
PHARMA
IPC
A01B
下载范围
下载第
到
条记录。
下载内容
题录信息
专利全文